Acetic Acid → (4'-Chloro-2-{6-[1-cyclohexyl-5-(1h-tetrazol-5-yl)-1h-benzoimidazol-2-yl]-quinolin-2-yl}-biphenyl-4-yl)-pyrrolidin-1-yl-methanone
반응식
[Cl:1][C:2]1[CH:33]=[CH:32][C:5]([C:6]2[C:11](C3C=CC4C(=CC=C(C(O)=O)C=4)N=3)=[CH:10][C:9]([C:25]([N:27]3[CH2:31][CH2:30][CH2:29][CH2:28]3)=[O:26])=[CH:8][CH:7]=2)=[CH:4][CH:3]=1.CN(C(O[N:42]1[N:50]=[N:49]C2C=CC=CC1=2)=[N+](C)C)C.F[P-](F)(F)(F)(F)F.C(O[C:61]([C:63]1[CH:64]=[C:65]2[N:71]=[C:70]([C:72]3[CH:73]=[C:74]4[C:79](=[CH:80][CH:81]=3)[N:78]=[C:77](C3C=CC=CC=3Br)[CH:76]=[CH:75]4)[N:69]([CH:89]3[CH2:94][CH2:93][CH2:92][CH2:91][CH2:90]3)[C:66]2=[N:67][CH:68]=1)=O)C.[CH3:95]C(O)=O>>[Cl:1][C:2]1[CH:33]=[CH:32][C:5]([C:6]2[CH:11]=[CH:10][C:9]([C:25]([N:27]3[CH2:31][CH2:30][CH2:29][CH2:28]3)=[O:26])=[CH:8][C:7]=2[C:77]2[CH:76]=[CH:75][C:74]3[C:79](=[CH:80][CH:81]=[C:72]([C:70]4[N:69]([CH:89]5[CH2:90][CH2:91][CH2:92][CH2:93][CH2:94]5)[C:66]5[CH:95]=[CH:61][C:63]([C:68]6[NH:67][N:42]=[N:50][N:49]=6)=[CH:64][C:65]=5[N:71]=4)[CH:73]=3)[N:78]=2)=[CH:4][CH:3]=1참가 물질
5
반응물 4
생성물 1
실험 절차
The amine was reacted with Compound 259e (0.125 g, 0.274 mmol) in the presence of HBTU (0.114 g, 0.30 mmol), followed cyclization in AcOH according to procedures described for the preparation of Compound 477d. Separation by RP HPLC (from 10% of buffer B to 85% of buffer B) gave the title compound (42 mg, 23%).
후처리
- customSeparation by RP HPLC (from 10% of buffer B to 85% of buffer B)
출처 및 근거
- ORD 기록
- ord-888263f4fc154cd191ba199a1d5df0a7
- 출처 데이터셋
- uspto-grants-2009_03
- 특허 번호
- US07511145B2
반응 노트
불러오는 중…